FDA sued for failing to act on painkiller

A consumer group has sued the FDA, saying the agency has been too slow in acting against the painkiller known as Darvon, a.k.a. propoxyphene. In its suit, Public Citizen says FDA broke the law by not ruling on its petition against drug, which it filed two years ago. The agency was required to act on it within six months, the suit says. Report

Suggested Articles

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.